Tuesday, November 12, 2013

Suven Life Sciences - Q2 Result Update

Financial Results with Results Press Release & Limited Review for Sept 30, 2013
Link: Click Here

Communication to investors - Sep 2013
Link: Click Here

Once again the company was successful in delivering numbers which proved to be way beyond expectation of many, and hence the stock continues to be in strong upside momentum.
Below post was written on 4th June 2013, when the stock was trading around 25 levels, and in just 5 months, it has appreciated to 80 levels, the growth of more than 200%.
http://fundamentalstockideas.in/few-more-multibaggers-for-long-term/

Sales showed a 202% growth from 50.3 Cr to 151.5 Cr YoY.
Revenues showed an even better growth of 602% from 6.5 Cr to 45.5 Cr YoY.
As per company, the major thrust in net profit was due to in 1 new product, in addition to 2 products which were already commercialized during first quarter.
EPS now stands at 3.9 from 0.56 YoY.
There was something exciting in Expense segment also, where the R&D expense shooted up to 17.9 Cr from 6.83 Cr last year, which might further help the company in growing stronger.

My Views:
Not sure about new entries, but those holding can continue to hold, if they still have guts to hold for longer term. I am also positive for new entries also looking at the R&D expense of the company. The only worry is that the stock price has already appreciated more than 200% in last 5 months, but still, you never know what levels are sufficient to justify strong growth performance by the company.

12 comments:

  1. Infinite computers once again came out with flat numbers, considering the favourable environment for IT companies..
    Again, for now, I would the stock seems fairly valued in 120-130 range...unless there is some news or speculations...

    ReplyDelete
  2. Capri Global Capital also came out with numbers yesterday, and they once again showed a good growth in gross sales, and net sales increased by 20%, which is good, but net profit remained flat, due to which might not get immediate reaction....

    ReplyDelete
  3. hello kunal,
    hope u r enjoying results season.
    I am holding major of my portfolio in pharma companies like suven granules etc those are getting revenues from export mostly.
    What if us defaults on its debt some day..... I mean impact on exporting pharma companies? worried as a long term investor... need your views.

    ReplyDelete
  4. Hi Vivek,

    Yeah, I m enjoying the results season, in a way that, most of the companies has come out with good numbers, but also hectic, in a way, that I have to write too many posts very frequently, its a little tiring. :-)

    I personally feel, that its very far now, to think about what will happen if US defaults, because they will always figure out a way here and there, and manage it, just to avoid default. The reason is simple. If you remember, in 2008, when just 1 financial institution went bankrupt, the whole world faced a strong depression, so think about what will happen when the whole country defaults.

    I will give you 1 very good article on this:
    http://money.cnn.com/2013/10/15/investing/debt-default-doomsday/

    For now, I would say, lets not think about it.
    But in any case, to answer your question, if US defaults, then forget about pharma, I would say the time would be even worse than 2008 for sure.

    FYI, if you are interested in their debt situation and all, refer this site.
    http://usdebtclock.org/
    Its a live counter of US debt, and look how its increasing every second (if your browser is fast enough to load it fully ;-) )
    The debt limit earlier, due to which the government shut down in Oct, was $16.7 Trillion.
    In less than a month, the debt now stands at $17.1 Trillion.
    Just imagine the pace with which it is increasing.

    ReplyDelete
  5. Cravatex came out with numbers today, and again it was a mixed result, where revenues grew by more than expected, 17.5%, but net profit literally reduced to 1/3rd of last year same quarter.
    Good to see revenues growing, but in this environment of weak rupee, they are always going to struggle for making profits. Hence it will be difficult for the stock to go back to earlier levels.

    ReplyDelete
  6. CRISIL maintains fair value of Rs 615 to Cera Sanitaryware
    Link: http://www.moneycontrol.com/news/crisilresearch/crisil-maintains-fair-valuers-615-to-cera-sanitaryware_987754.html

    ReplyDelete
  7. Photoquip second quarter results are out !!!! It has turned the corner :-)

    ReplyDelete
  8. But it will take some time for LED (Corvi) business to break-even. However, your detailed comments are solicited.

    ReplyDelete
  9. It certainly has turned the corner, but its just a start..... consistency is appreciated by markets rather than one time show.....
    Good that you added few in past days, we might be able to see happy days coming again, if the results continue to impress further....

    ReplyDelete
  10. Dear Kunal,
    Please check the new Corvi Led ad on youtube http://m.youtube.com/watch?v=wSiLIlvGY6k

    ReplyDelete
  11. Thank you so much for sharing..... as looks superb... great find!!!!

    ReplyDelete
  12. Will come out with post of Photoquip Q2 numbers on this weekend.
    The delay is because, I still need to fetch certain details regarding the business.
    Hopefully, I will get something by this weekend...

    ReplyDelete